MK615, a prospective anti-proliferative agent, enhances CD4/CD8 ratio after exposure to irradiation

International Journal of Radiation Biology

Volumn 87, Issue 1, 2011, Pages 81-90

  Al Jahdari, Wael S ^a,b   Sakurai, Hideyuki ^a   Yoshida, Yukari ^a,c   Mobaraki, Abdulelah ^a   Suzuki, Yoshiyuki ^a   Nakano, Takashi ^a,c  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

CD4 CD8 ratio; irradiation; MK615; triterpenoids

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INDOMETACIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CARCINOMA CELL; CD4 CD8 RATIO; CELLULAR IMMUNITY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INOCULATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOMA CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; SPLEEN; SURVIVAL TIME; X IRRADIATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CD4-CD8 RATIO; CELL LINE, TUMOR; CELL SURVIVAL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNITY, CELLULAR; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS;

MUS; PRUNUS MUME;

EID: 78650085842     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2010.518202     Document Type: Article

References (45)

1. Adachi M, Suzuki Y, Mizuta T, Osawa T, Adachi T, Osaka K, Suzuki K, Shiojima K, Arai Y, Masuda K, Uchiyama M, Oyamada T, Clerici M. 2007. The 'Prunus mume Sieb. et Zucc' (ume) is a rich natural source of noval anti-cancer substance. International Journal of Food Properities 10:375-384. (Pubitemid 46676584)
2. Akihisa T, Yasukawa K, Oinuma H, Kasahara Y, Yamanouchi S, Takido M, Kumaki K, Tamura T. 1996. Triterpene alcohols from the flowers of compositae and their anti-inflammatory effects. Phytochemistry 43:1255-1260. (Pubitemid 27108304)
3. Altmann H, Tuschl H. 1978. DNA-repair in lymphocytes of persons living in elevated natural background radiation areas (Badgastein). Late biological effects of ionizing radiation. Wien: IAEA.
4. Brinkhaus B, Lindner M, Schuppan D, Hahn EG. Chemical, pharmacological and clinical profile of the East Asian medical plant Centella asiatica. Phytomedicine 7:427-448.
5. Briot E, Dutreix A, Bridier A. 1990. Dosimetry for total body irradiation. Radiotherapy & Oncology 18(Suppl. 1):16-29.
6. Cohen PA, Peng L, Kjaergaard J, Plautz GE, Finke JH, Koski GK, Czerniecki BJ, Shu S. 2001. T-cell adoptive therapy of tumors: Mechanisms of improved therapeutic performance. Critical Reviews in Immunology 21:215-248. (Pubitemid 32959363)
7. Corthay A, Skovseth DK, Lundin KU, Rosjo E, Omholt H, Hofgaard PO, Haraldsen G, Bogen B. 2005. Primary antitumour immune response mediated by CD4+ T cells. Immunity 22:371-383. (Pubitemid 40387478)
8. Ganss R, Ryschich E, Klar E, Arnold B, Hammerling GJ. 2002. Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication. Cancer Research 62:1462-1470. (Pubitemid 34407808)
9. Hasler A, Sticher O, Meier B. 1990. High-performance liquid chromatographic determination of five widespread flavonoid aglycones. Journal of Chromatography A 508:236-240. (Pubitemid 20171135)
10. Hersey P, Menzies SW, Halliday GM, Nguyen T, Farrelly ML, DeSilva C, Lett M. 2004. Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma. Cancer Immunology Immunotherapy 53:125-134. (Pubitemid 38161219)
11. Hung K, Hayashi R, Lafond-Walker A, Lowenstein C, Pardoll D, Levitsky H. 1998. The central role of CD4(+) T cells in the antitumor immune response. Journal of Experimental Medicine 188:2357-2368. (Pubitemid 29028508)
12. Husmann LA, Bevan MJ. 1988. Cooperation between helper T cells and cytotoxic T lymphocyte precursors. Annals of the NewYork Academy of Sciences 532:158-169. (Pubitemid 19017636)
13. Jang SM, Yee ST, Choi J, Choi MS, Do GM, Jeon SM, Yeo J, Kim MJ, Seo KI, Lee MK. 2009. Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin-induced diabetic mice fed a high-fat diet. International Immunopharmacology 9:113-119.
14. Jiang RW, Lane AL, Mylacraine L, Hardcastle KI, Fairchild CR, Aalbersberg W, Hay ME, Kubanek J. 2008. Structures and absolute configurations of sulfate-conjugated triterpenoids including an antifungal chemical defense of the green macroalga Tydemania expeditionis. Journal of Natural Products 71:1616-1619.
15. Job G, Pfreundschuh M, Bauer M, zum WK, Hunstein W. 1984. The influence of radiation therapy on T-lymphocyte subpopulations defined by monoclonal antibodies. International Journal of Radiation Oncololog Biology Physics 10:2077-2081. (Pubitemid 15215794)
16. Johnke RM, Edwards JM, Kovacs CJ, Evans MJ, Daly BM, Karlsson UL, Lee TK, Allison RR, Arastu HH, Cariveau MJ, O'Brien KF. 2005. Response of T lymphocyte populations in prostate cancer patients undergoing radiotherapy: Influence of neoajuvant total androgen suppression. Anticancer Research 25:3159-3166. (Pubitemid 41044714)
17. Keene JA, Forman J. 1982. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. Journal of Experimental Medicine 15:768-782. (Pubitemid 12187851)
18. Kimoto T, Arai S, Kohguchi M, Aga M, Nomura Y, Micallef MJ, Kurimoto M, Mito K. 1998. Apoptosis and suppression of tumor growth by artepillin C extracted from Brazilian propolis. Cancer Detection and Prevention 22:506-515. (Pubitemid 28537432)
19. Leer JW, Broerse JJ, De VH, Chin A, Noordijk EM, Dutreix A. 1990. Techniques applied for total body irradiation. Radiotherapy & Oncology 18(Suppl. 1):10-15.
20. Lissoni P, Meregalli S, Bonetto E, MancusoM, Brivio F, Colciago M, Gardani G. 2005. Radiotherapy-induced lymphocytopenia: Changes in total lymphocyte count and in lymphocyte subpopulations under pelvic irradiation in gynecologic neoplasms. Journal of Biological Regulators and Homeosttic Agents 19:153-158. (Pubitemid 351515919)
21. Manez S, Recio MC, Giner RM, Rios JL. 1997. Effect of selected triterpenoids on chronic dermal inflammation. Europian Journal of Pharmacology 334:103-105. (Pubitemid 27417816)
22. Marciani DJ, Press JB, Reynolds RC, Pathak AK, Pathak V, Gundy LE, Farmer JT, Koratich MS, May RD. 2000. Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity. Vaccine 18:3141-3151. (Pubitemid 30345696)
23. Mitchell MS, Darrah D, Yeung D, Halpern S, Wallace A, Voland J, Jones V, Kan-Mitchell J. 2002. Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope. Journal of Clinical Oncology 20: 1075-1086. (Pubitemid 34141853)
24. Mori S, Sawada T, Okada T, Ohsawa T, Adachi M, Keiichi K. 2007. New anti-proliferative agent, MK615, from Japanese apricot 'Prunus mume' induces striking autophagy in colon cancer cells in vitro. World Journal of Gastroenterology 13: 6512-6517.
25. Morimoto Y, Kikuchi K, Ito T, Tokuda M, Matsuyama T, Noma S, Hashiguchi T, ToriiM,Maruyama I,KawaharaK. 2009. MK615 attenuates Porphyromonas gingivalis lipopolysaccharide-induced pro-inflammatory cytokine release via MAPK inactivation in murine macrophage-like RAW264.7 cells. Biochemical and Biophysical Research Communications 389:90-94.
26. Mumberg D, Monach PA, Wanderling S, Philip M, Toledano AY, Schreiber RD, Schreiber H. 1999. CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma. Proceedings of the National Academy of Sciences of the USA 96:8633-8638. (Pubitemid 29354843)
27. Nakagawa A, Sawada T, Okada T, Ohsawa T, Adachi M, Kubota K. 2007. New antineoplastic agent, MK615, from UME (a variety of) Japanese apricot inhibits growth of breast cancer cells in vitro. Breast Journal 13:44-49. (Pubitemid 46046492)
28. Nocerino E, Amato M, Izzo AA. 2000b. Cannabis and cannabinoid receptors. Fitoterapia (Suppl. 1):S6-12. (Pubitemid 30621689)
29. Nocerino E, Amato M, Izzo AA. 2000a. The aphrodisiac and adaptogenic properties of ginseng. Fitoterapia 71(Suppl. 1): S1-5. (Pubitemid 30621688)
30. Okada T, Sawada T, Osawa T. 2007. A novel anti-cancer substance, MK615, from ume, a variety of Japanese apricot, inhibits growth of hepatocellular carcinoma cells by suppressing Aurora A kinase activity. Hepatogastroenterology 54: 1770-1774. (Pubitemid 350068475)
31. Okada T, Sawada T, Osawa T, Adachi M, Kubota K. 2008. MK615 inhibits pancreatic cancer cell growth by dual inhibition of Aurora A and B kinases. World Journal of Gastroenterology 14:1378-1382. (Pubitemid 351425217)
32. Pardoll DM, Topalian SL. 1998. The role of CD4+ T cell responses in antitumor immunity. Current Opinion in Immunology 10:588-594. (Pubitemid 28479193)
33. Park HR, Jung U, Jo SK. 2007. Impairment of natural killer (NK) cells is an important factor in a weak Th1-like response in irradiated mice. Radiation Research 168:446-452. (Pubitemid 351303173)
34. Perez-Diez A, Joncker NT, Choi K, Chan WF, Anderson CC, Lantz O, Matzinger P. 2007. CD4 cells can be more efficient at tumor rejection than CD8 cells. Blood 109:5346-5354. (Pubitemid 46890556)
35. Powell DJ Jr, Dudley ME, Hogan KA, Wunderlich JR, Rosenberg SA. 2006. Adoptive transfer of vaccine-induced peripheral blood mononuclear cells to patients with metastatic melanoma following lymphodepletion. Journal of Immunology 177:6527-6539. (Pubitemid 44628872)
36. Qin Z, Blankenstein T. 2000. CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells. Immunity 12:677-686.
37. Rao AV, Gurfinkel DM. 2000. The bioactivity of saponins: Triterpenoid and steroidal glycosides. Drug Metabolism and Drug Interactions 17:211-235. (Pubitemid 32047536)
38. Schuler-Thurner B, Schultz ES, Berger TG, Weinlich G, Ebner S, Woerl P, Bender A, Feuerstein B, Fritsch PO, Romani N, Schuler G. 2002. Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. Journal of Experimental Medicine 195:1279-1288. (Pubitemid 34564330)
39. Shank B. 1983. Techniques of magna-field irradiation. International Journal of Radiation Oncololog Biology Physics 9:1925-1931. (Pubitemid 14178676)
40. Speiser DE, Pittet MJ, Rimoldi D, Guillaume P, Luescher IF, Lienard D, Lejeune F, Cerottini JC, Romero P. 2003. Evaluation of melanoma vaccines with molecularly defined antigens by ex vivo monitoring of tumor-specific T cells. Seminars in Cancer Biology 13:461-472. (Pubitemid 38156138)
41. Takasaki M, Konoshima T, Murata Y, Sugiura M, Nishino H, Tokuda H, Matsumoto K, Kasai R, Yamasaki K. 2003. Anticarcinogenic activity of natural sweeteners, cucurbitane glycosides, from Momordica grosvenori. Cancer Letter 198: 37-42. (Pubitemid 37289101)
42. Wang RF. 2006. Immune suppression by tumor-specific CD4+ regulatory T-cells in cancer. Seminars in Cancer Biology 16:73-79.
43. Wasik M, Gorska E, Modzelewska M, Nowicki K, Jakubczak B, Demkow U. 2007. The influence of low-power helium-neon laser irradiation on function of selected peripheral blood cells [abstract]. In: The influence of low-power helium-neon laser irradiation on function of selected peripheral blood cells. Journal of Physiology and Pharmacology 58(Suppl. 5)Pt 2: 729-737.
44. Yamai H, Sawada N, Yoshida T, Seike J, Takizawa H, Kenzaki K, Miyoshi T, Kondo K, Bando Y, Ohnishi Y, Tangoku A. 2009. Triterpenes augment the inhibitory effects of anticancer drugs on growth of human esophageal carcinoma cells in vitro and suppress experimental metastasis in vivo. International Journal of Cancer 125:952-960.
45. Yee C, Thompson JA, Byrd D, Riddell SR, Roche P, Celis E, Greenberg PD. 2002. Adoptive T cell therapy using antigenspecific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells. Proceedings of the National Academy of Sciences of the USA 99:16168-16173. (Pubitemid 35462767)